Please wait while the formulary information is being retrieved.
CABERGOLINE (CABERGOLINE)
- Hyperprolactinemia
0.5 mg tablet
- 1 tablet (0.5 mg) by oral route twice weekly
Hyperprolactinemia
- 1 tablet (0.5 mg) by oral route twice weekly
- 2 tablets (1 mg) by oral route twice weekly
- metoclopramide HCl
- Metozolv Odt
- Reglan
Contraindicated
- Abilify
- Abilify Discmelt
- Abilify Maintena
- Adasuve
- aripiprazole
- asenapine
- chlorpromazine
- Compazine
- Compro
- droperidol
- fluphenazine decanoate
- fluphenazine HCl
- Geodon
- Haldol
- Haldol Decanoate
- haloperidol
- haloperidol decanoate
- haloperidol lactate
- Invega
- Invega Sustenna
- Latuda
- loxapine
- loxapine succinate
- Loxitane
- lurasidone
- olanzapine
- olanzapine pamoate
- olanzapine-fluoxetine
- Orap
- paliperidone
- paliperidone palmitate
- perphenazine
- perphenazine-amitriptyline
- pimozide
- prochlorperazine
- prochlorperazine Edisylate
- prochlorperazine maleate
- quetiapine
- Risperdal
- Risperdal Consta
- Risperdal M-tab
- risperidone
- risperidone microspheres
- Saphris
- Saphris (black Cherry)
- Seroquel
- Seroquel Xr
- Symbyax
- thioridazine
- thiothixene
- trifluoperazine
- ziprasidone HCl
- ziprasidone mesylate
- Zyprexa
- Zyprexa Relprevv
- Zyprexa Zydis
Severe
Moderate
- None
- Fibrosis of pericardium
- Lactating mother
- Pulmonary fibrosis
- Retroperitoneal fibrosis
- Severe uncontrolled hypertension
- Valvular heart disease
Contraindicated
- Occlusive vascular disease
- Severe pre-eclampsia
Severe
Moderate
- Disease of liver
CABERGOLINE (CABERGOLINE)
- Hyperprolactinemia
- None
- Constipation
- Dizziness
- Headache disorder
- Nausea
More Frequent
Severe
Less Severe
- Orthostatic hypotension
- Vertigo
- Acute abdominal pain
- Arthralgias
- Concentration difficulty
- Depression
- Drowsy
- Dyspepsia
- Fatigue
- Flushing
- General weakness
- Mastalgia
- Myalgias
- Nervousness
- Paresthesia
- Rhinitis
- Sore throat
- Toothache
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anorexia
- Constrictive pericarditis
- Drug-induced psychosis
- Fibrosis of pericardium
- Fibrotic drug-induced cardiac valvulopathy
- Heart failure
- Hypotension
- Kidney disease with reduction in GFR
- Periorbital edema
- Peripheral edema
- Pleural effusions
- Pleural fibrosis
- Pulmonary fibrosis
- Retroperitoneal fibrosis
- Syncope
Less Severe
- Acne vulgaris
- Acute confusion
- Aggressive behavior
- Alopecia
- Diarrhea
- Dyskinesia
- Dysmenorrhea
- Epistaxis
- Facial edema
- Flatulence
- Flu-like symptoms
- Hallucinations
- Impulse control disorder
- Increased libido
- Insomnia
- Malaise
- Palpitations
- Pruritus of skin
- Visual changes
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Cabergoline
Safety and efficacy not established in pediatrics.
- 1 Day – 18 Years
- Safety and efficacy not established in pediatrics.
Cabergoline
- Severity Level:
B
- Additional Notes:
Contraindicated
Cabergoline
Not recommended; interferes with lactation.
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Not recommended; interferes with lactation. |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Cabergoline
Cardiovascular-Starting doses higher than 1.0 mg may produce orthostatic hypotension. Hepatic-Extensively metabolized in the liver. Caution in elderly with decreased hepatic blood flow.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | Y | Y | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Hyperprolactinemia | |
| E22.1 | Hyperprolactinemia |
| 0-9 | A-Z |
|---|---|
| E22.1 | Hyperprolactinemia |
Formulary Reference Tool